Pulse lineResearch With Heart Logo

ARIC Publications

Filters: First Letter Of Last Name is L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Lee AK, Lee CJ, Huang ES, Sharrett ARichey, Coresh JJ. "Risk Factors for Severe Hypoglycemia in Black and White Adults With Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study." Diabetes Care. 2017;40(12):1661-1667.
Lazo M, Chen Y, McEvoy JW, et al. "Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study." Clin Chem. 2016;62(9):1202-10.
Lazo M, Young HJ, Brancati FL, et al. "NH2-terminal pro-brain natriuretic peptide and risk of diabetes." Diabetes. 2013;62(9):3189-93.
Lazo M, Halushka MK, Shen L, et al. "Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study." Am Heart J. 2015;170(5):961-7.
Lazo M, Rubin J, Clark JM, et al. "The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease." J Hepatol. 2015;62(4):841-7.
Lazarus B, Wu A, Shin J-I, et al. "Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study." JAMA Intern Med. 2018;178(7):903-910.
Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh JJ. "Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease." JAMA Intern Med. 2016;176(2):238-46.
Lawani SO, Demerath EW, Norby FL, Soliman EZ, Huxley RR, Rose KM. "Birth weight and the risk of atrial fibrillation in whites and African Americans: the Atherosclerosis Risk In Communities (ARIC) study." BMC Cardiovasc Disord. 2014;14:69.
Laudenslager M, Lazo M, Wang D, et al. "Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study." Dig Liver Dis. 2021.
Larsson SC, Traylor M, Burgess S, Boncoraglio GB, Jern C, Michaëlsson K. "Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study." Neurology. 2019;92(9):e944-e950.
Larson N, Hutchinson R, Boerwinkle E. "Lack of association of 3 functional gene variants with hypertension in African Americans." Hypertension. 2000;35(6):1297-300.
Lange LA, Hu Y, Zhang H, et al. "Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol." Am J Hum Genet. 2014;94(2):233-45.
Lamprea-Montealegre JA, Sharrett ARichey, Matsushita K, Selvin E, Szklo M. "Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study." Atherosclerosis. 2014;234(1):42-6.
Lamichhane AP, Couper DJ, Jenkins GP. "Longitudinal Associations Between Body Mass Index During Young Adulthood, Subsequent Weight Change, and Incident Diabetes During Mid- and Older-Adulthood in Non-Hispanic White and African American Populations: The Atherosclerosis Risk in Communities Study." Metab Syndr Relat Disord. 2020;18(7):313-320.
Lalani SR, Liu P, Rosenfeld JA, et al. "Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations." Am J Hum Genet. 2016;98(2):347-57.
Lagou V, Mägi R, Hottenga J-Jan, et al. "Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability." Nat Commun. 2021;12(1):24.
Lacy ME, Wellenius GA, Carnethon MR, et al. "Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA Study." Diabetes Care. 2016;39(2):285-91.